Your browser doesn't support javascript.
loading
Primary tumor sidedness and benefit from FOLFOXIRI plus bevacizumab as initial therapy for metastatic colorectal cancer. Retrospective analysis of the TRIBE trial by GONO.
Cremolini, C; Antoniotti, C; Lonardi, S; Bergamo, F; Cortesi, E; Tomasello, G; Moretto, R; Ronzoni, M; Racca, P; Loupakis, F; Zaniboni, A; Tonini, G; Buonadonna, A; Marmorino, F; Allegrini, G; Granetto, C; Masi, G; Zagonel, V; Sensi, E; Fontanini, G; Boni, L; Falcone, A.
Afiliación
  • Cremolini C; Unit of Medical Oncology 2, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy; Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy. Electronic address: chiaracremolini@gmail.com.
  • Antoniotti C; Unit of Medical Oncology 2, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy; Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.
  • Lonardi S; Unit of Medical Oncology 1, Department of Clinical and Experimental Oncology, Istituto Oncologico Veneto IRCCS, Padua, Italy.
  • Bergamo F; Unit of Medical Oncology 1, Department of Clinical and Experimental Oncology, Istituto Oncologico Veneto IRCCS, Padua, Italy.
  • Cortesi E; Department of Medical Oncology, University of Rome La Sapienza, Rome, Italy.
  • Tomasello G; Oncology Department, ASST Ospedale di Cremona, Cremona, Italy.
  • Moretto R; Unit of Medical Oncology 2, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy; Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.
  • Ronzoni M; Department of Oncology, "San Raffaele" Hospital IRCSS, Milan, Italy.
  • Racca P; SSD ColoRectal Unit-Department of Medical Oncology, AOU Città della Salute e della Scienza di Torino, Turin, Italy.
  • Loupakis F; Unit of Medical Oncology 2, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy; Unit of Medical Oncology 1, Department of Clinical and Experimental Oncology, Istituto Oncologico Veneto IRCCS, Padua, Italy.
  • Zaniboni A; Department of Medical Oncology, Poliambulanza Foundation, Brescia, Italy.
  • Tonini G; Department of Medical Oncology, University Campus Biomedico, Rome, Italy.
  • Buonadonna A; Division of Oncology, Centro di Riferimento Oncologico, Aviano, Italy.
  • Marmorino F; Unit of Medical Oncology 2, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy; Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.
  • Allegrini G; Unit of Medical Oncology, Hospital Felice Lotti, Azienda Toscana Nord Ovest, Pontedera, Italy.
  • Granetto C; Unit of Medical Oncology, Azienda Sanitaria Ospedaliera Santa Croce e Carle, Cuneo, Italy.
  • Masi G; Unit of Medical Oncology 2, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy; Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.
  • Zagonel V; Unit of Medical Oncology 1, Department of Clinical and Experimental Oncology, Istituto Oncologico Veneto IRCCS, Padua, Italy.
  • Sensi E; Unit of Pathology 3, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy.
  • Fontanini G; Department of Surgical, Medical, Molecular Pathology and Critical Area, University of Pisa, Pisa, Italy.
  • Boni L; Clinical Trials Coordinating Center, Istituto Toscano Tumori, University Hospital Careggi, Florence, Italy.
  • Falcone A; Unit of Medical Oncology 2, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy; Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.
Ann Oncol ; 29(7): 1528-1534, 2018 07.
Article en En | MEDLINE | ID: mdl-29873679

Texto completo: 1 Colección: 01-internacional Tipo de estudio: Clinical_trials / Risk_factors_studies Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2018 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Tipo de estudio: Clinical_trials / Risk_factors_studies Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2018 Tipo del documento: Article